ANCILLARY PATHWAYS, LLC.
MIAMI, FLORIDA

Ancillary Pathways, LLC is a specialty anatomic pathology service company founded by Dr. Hadi Yaziji, M.D., renowned for his leadership in immunohistochemistry (IHC) and fluorescence in-situ hybridization (FISH) testing within the field of pathology. Headquartered in Miami, Florida, Ancillary Pathways addresses resource-related challenges faced by pathology laboratories through outsourcing services designed to cater to a wide range of laboratory settings. Established on November 2, 2005, under Florida business laws, the company holds the registered Filed Number L05000106877 and operates as a Foreign Limited Liability Corporation (FLAL). Ancillary Pathways stands out for providing bespoke training and logistical support to enhance its clients' IHC and FISH capabilities by leveraging expertise from an extensive network of experienced pathologists, scientists, and technologically adept professionals. The company's Advisory Board comprises internationally acknowledged physicians and technologists contributing towards its robust service offerings. Located at 8700 W Flagler St STE 100, Miami FL, Ancillary Pathways maintains active communication through phone numbers (305) 912-7522 and (786) 513-0175. Further information can be accessed on their website at ancillarypathways.com, with their last significant administrative event noted on April 24, 2020.